Examination of the possible mediation of antineoplastic effects of opiates through the inhibition of tyrosine-specific protein kinases.
Burke
T R
TR
Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Li
Z H
ZH
Bolen
J B
JB
Chapekar
M
M
Gang
Y
Y
Glazer
R I
RI
Rice
K C
KC
Marquez
V E
VE
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002460:Cell Line; D066246:ErbB Receptors / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006873:Hydroquinones / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology*; D010620:Phenazocine / Q000494:pharmacology; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D006873:Hydroquinones; D009294:Narcotics; D009020:Morphine; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D010620:Phenazocine; C048212:erbstatin